| 000 | 01873 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516012217.0 | ||
| 264 | 0 | _c20101215 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1128-3602 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Luis, D A | |
| 245 | 0 | 0 |
_aEffects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women. _h[electronic resource] |
| 260 |
_bEuropean review for medical and pharmacological sciences _cSep 2010 |
||
| 300 |
_a759-63 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xblood |
| 650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aIrbesartan |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNicotinamide Phosphoribosyltransferase _xblood |
| 650 | 0 | 4 |
_aObesity _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aConde, R | |
| 700 | 1 | _aGonzalez Sagrado, M | |
| 700 | 1 | _aAller, R | |
| 700 | 1 | _aIzaola, O | |
| 700 | 1 | _aPerez Castrillon, J L | |
| 700 | 1 | _aRomero, E | |
| 700 | 1 | _aCastro, M J | |
| 773 | 0 |
_tEuropean review for medical and pharmacological sciences _gvol. 14 _gno. 9 _gp. 759-63 |
|
| 999 |
_c20360172 _d20360172 |
||